>
COMMANDS Global: GP Symbol: IBM FA
↑↓ Navigate Enter Open Esc Close ` Toggle

CompanyHeadlineTime (ET)
INTCTop 5 Stocks That Will Profit From Nvidia's PC Market Invasion of Intel Territory06/01 08:33
ABXXFAbaxx Exchange Reports Record May 2026 Trading Volume, Including Record LNG Activity06/01 08:33
SPYThe S&P 500 Lost 40% in Real Terms from 1968 to 1982. History Says It Could Happen Again.06/01 08:32
ZZillow downgrades its home price forecast across 400-plus housing markets—see the data06/01 08:31
GTLLRezolve Ai Positioned at the Heart of the AI Transformation of $30 Trillion Global Retail, Reiterates $360M+ FY26 Revenue Guidance06/01 08:31
NXTNextpower Files Patent Lawsuit Against GameChange Solar06/01 08:31
VLOValero Energy Is A 'Buy' As Refining Tailwinds Still Have Plenty Of Runway06/01 08:30
HLTHilton Launches Undergraduate by Hilton, Accelerating Lifestyle Portfolio Growth06/01 08:30
MHOM/I Homes Engages Prophetic for Land Acquisition Technology Support06/01 08:30
VATEINNOVATE Announces Successful Closing of Broadcasting Refinancing and Agrees to Partial Sale of Broadcasting06/01 08:30
DRIIN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 202606/01 08:30
INCNATURE'S MIRACLE HOLDING INC. SECURES $566,000 CONVERTIBLE PREFERRED STOCK FINANCING06/01 08:30
RMCFRocky Mountain Chocolate Factory Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results06/01 08:30
EWTXEdgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline06/01 08:30
AIREreAlpha (NASDAQ: AIRE) to Host “AIRE Time With Mike” Fireside Chat Moderated by Benchmark Analyst Daniel Kurnos06/01 08:30
AMPXAmprius Sets June 2026 Events Schedule06/01 08:30
FRFirst Industrial to Present at Nareit's REITWeek 2026 Investor Conference06/01 08:30
EPPDisc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients06/01 08:30
CELCCelcuity to Hold Conference Call to Discuss Results for the PIK3CA Mutant Cohort of the Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib Regimens in HR+/HER- Advanced Breast Cancer on June 2, 202606/01 08:30
ULCCCommvault Encourages Organizations to Adopt a Four-Step Approach to Resilience in the Age of Frontier AI06/01 08:30

Market News ×
Loading news…